Table 4. Relevant factors associated with recurrence after complete response to progestin treatment (n=11)
Variables Recurrence p value
Age
<35 ≥35		  
10/15 (66.7%)
1/5 (20%)		  
0.127
Body Mass Index
< 30
≥30		  
1/9 (11.1%)
10/11 (90.9%)		  
0.001
Diabetes Mellitus
Yes
No		  
5/10 (50%)
6/10 (60%)		  
1.000
Polycystic Ovarian Syndrome
Yes
No		  
9/14 (64.3%)
2/6 (33.3%)		   0.336
Histopathology
Atypical
Endometrial cancer		  
10/19 (52.63%)
1/1 (100%)		  
0.304
Progestin Type
Megestrol Acetate
Mirena Coil
Megesterol+Mirena		  
5/11 (45.6%)
0/1 (0%)
6/8 (75%)		  
0.299
Time to complete remission
6 months
>6 months		  
3/11 (27.3%)
8/9 (88.9%)		  
0.010
Pregnancies after progestogens
Yes
No		  
6/12 (50%)
5/8 (62.5%)		  
0.670